Totaluppereyelidreconstructionwith temporal advancement-transpositionflap, combinedwithan oral mucosalgraft. Case report
DOI:
https://doi.org/10.31837/cir.urug/9.1.14Keywords:
Sebaceous carcinoma, upper eyelid reconstructionAbstract
Sebaceous carcinoma is a rare andpotentially aggressive glandular neoplasm, with the most common site of presentation being the upper eyelid. Its clinical manifestation can vary. The usual treatment involves conventional resection or Mohs micrographic surgery, followed by appropriate reconstruction.Objective: To describe the reconstructive technique for managing a total defect of the upper eyelid using an advancement and transposition flap from the temporal region, combined with an oral mucosa graft in a single surgical procedure. Material and Methods: A clinical case is presented of a patient with sebaceous carcinoma of the upper eyelid, who underwent tumor resection followed by reconstruction using a transposition and advancement flap from the temporal region, with an oral mucosa graft. Discussion and Conclusions: The described technique is an effective option for reconstructing extensive upper eyelid defects. Its main advantage lies in the dynamic reconstruction of the eyelid, with minimal morbidity at the donor site and a skin texture and color similar to that of the temporal region. Additionally, it is performed in a single surgical procedure, is technically simple, and is carried out within a single operative field.
Downloads
References
Owen JL, Kibbi N, Worley B, Kelm RC, Wang JV, Barker CA, et al. Sebaceous carcinoma: evidence-based clinical practice guidelines. Lancet Oncol. 2019;20(12):e699-e714.doi: 10.1016/S1470-2045(19)30673-4.
Ramírez García LK, Díaz Azze M, Gómez Cabrera CG, Vigoa Aranguren L, Rojas Rondón I, Carrazana Pérez YM. Carcinoma de glándulas sebáceas palpebrales. Rev Cubana Oftalmol. 2014;27( 1 ):139-47 http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21762014000100014&lng=es.
Arronte-Alarcon MT,Joan-Figueroa A, Rodríguez-Vázquez J, Rodríguez-Ramirez T, Melgares-Ramos M, Santos-Silva I, et. al. Sebaceous Glands carcinoma. A 10 years clinical-patogical study. Rev. Mex. Oftalmol. 2013;87(1):19-24.https://www.elsevier.es/es-revista-revista-mexicana-oftalmologia-321-articulo-carcinoma-glandulas-sebaceas-un-estudio-X0187451913949864
- Mc Lean IL, Bernier MN, Zimmerman LE.Tumors of the eye and ocular adnexa. Washington D.C.:1993. p. 7-47. (AFIP Atlas of tumor pathology Serie 3, n12).
Rao NA, Hidayat AA, McLean IW, Zimmerman LE. Sebaceous carcinomas of the ocular adnexa: a clinicopathologic study of 104 cases, with five-year follow-up data.Hum Pathol. 1982;13(2):113-22. doi: 10.1016/s0046-8177(82)80115-9.
Arango M, Montoya Carrasquilla DC, Velásquez MA. Sebaceous carcinoma oftheeyelid. Case Report. Rev. Sociedad Colombiana de Oftalmología. 2016; 49(2):127-34.
https://fi-admin.bvsalud.org/document/view/z6uzv
Cicinelli MV, Kaliki S. Ocular sebaceousgland carcinoma: anupdateoftheliteratura. Int Ophthalmol. Int Ophthalmol. 2019;39(5):1187-97. doi: 10.1007/s10792-018-0925-z.
Abullarade J. Reconstrucción completa y dinámica del párpado superior. Cir.plást. iberolatinoam. 2013;39(2):153-57.https://scielo.isciii.es/pdf/cpil/v39n2/original6.pdf
Harvey DT, Taylor RS, Itani KM, Loewinger RJ.Mohs micrographic surgery of the eyelid: an overview of anatomy, pathophysiology, and reconstruction options.Dermatol Surg. 2013;39(5):673-97. doi: 10.1111/dsu.12084.
DiFrancesco LM, Codner MA, McCord CD. Upper eyelid reconstruction.Plast ReconstrSurg. 2004;114(7):98e-107e. doi: 10.1097/01.prs.0000142743.57711.48.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles, videos and images published in Revista Cirugía del Uruguay are under the Creative Commons CC licenses, which is a complement to the traditional copyright, in the following terms: first, the authorship of the referred document must always be acknowledged and secondly none of the article or work published in the journal may have commercial purposes of any nature. The authors retain their copyrights and give the magazine the right of first publication of their work, which will be simultaneously subject to the Creative Commons Attribution-NonCommercial 4.0 International License license that allows the work to be shared whenever the initial publication is indicated in this journal.
